897
Views
4
CrossRef citations to date
0
Altmetric
HEMATOLOGICAL MALIGNANCY

Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA

, , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jipan Xie, Aozhou Wu, Laura Liao, Loretta J. Nastoupil, Ella Xiaoyan Du, Ahmed Noman & Lei Chen. (2021) Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving ≥3 therapy lines in post-CAR-T era. Current Medical Research and Opinion 37:10, pages 1789-1798.
Read now

Articles from other publishers (3)

Charanpreet Singh, Pankaj Malhotra, Aditya Jandial, Arihant Jain, Deepesh Lad, Alka Khadwal, Amanjit Bal, Ashim Das, BR Mittal & Gaurav Prakash. (2022) Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial). Indian Journal of Hematology and Blood Transfusion 39:1, pages 77-84.
Crossref
Xiaoqin Yang, François Laliberté, Guillaume Germain, Monika Raut, Mei Sheng Duh, Shuvayu S. Sen, Dominique Lejeune, Kaushal Desai & Philippe Armand. (2021) Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S. The Oncologist 26:5, pages e817-e826.
Crossref
Vicki A Morrison, Yaping Shou, Jill A Bell, Laurie Hamilton, Augustina Ogbonnaya, Aditya Raju, Kristin Hennenfent, Michael Eaddy & Aaron Galaznik. (2019) Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA. Future Oncology 15:9, pages 1021-1034.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.